Comparison of etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates

Journal of Clinical Microbiology

Volumn 35, Issue 4, 1997, Pages 1021-1023

  Hsueh, Po Ren ^a   Chang, Jen Chyi ^b   Teng, Lee Jene ^a,c   Yang, Pan Chyr ^a   Ho, Shen Wu ^a,c   Hsieh, Wei Chuan ^a   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; MINOCYCLINE; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; FLAVOBACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); FLAVOBACTERIUM;

EID: 0030964945     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.4.1021-1023.1997     Document Type: Article

References (22)

1. Aber, R. C., C. Wennersten, and R. C. Moellering, Jr. 1978. Antimicrobial susceptibility of flavobacteria. Antimicrob. Agents Chemother. 14:483-487.
2. Altmann, G., and B. Bogokovsky. 1971. In vitro sensitivity of Flavobacterium meningosepticum to antimicrobial agents. J. Med. Microbiol. 4:296-299.
3. Baker, C. N., S. A. Stocker, D. H. Culver, and C. Thornsberry. 1991. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 29:533-538.
4. Brown, D. F. J., and L. Brown. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27:185-190.
5. Brown, D. F. J. 1992. The E-Test challenged with selected strains. Diagn. Microbiol. Infect. Dis. 15:465-468.
6. Chang, J. C., P. R. Hsueh, J. J. Wu, W. C. Hsieh, and K. T. Luh. Antimicrobial susceptibility of flavobacteria: a comparison of agar dilution MICs and disk diffusion results. Submitted for publication.
7. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
8. Ferraro, M. J., and J. H. Jorgensen. 1995. Instrument-based antimicrobial susceptibility testing, p. 1379-1384. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
9. Hsueh, P. R., J. J. Wu, T. R. Hsiue, and W. C. Hsieh. 1995. Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin. Infect. Dis. 21: 1337-1338.
10. Hsueh, P. R., T. R. Hsiue, and W. C. Hsieh. 1996. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin. Infect. Dis. 22:858-860.
11. Hsueh, P. R., L. J. Teng, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1996. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J. Clin. Microbiol. 34:1908-1913.
12. Hsueh, P. R., T. R. Hsiue, J. J. Wu, L. J. Teng, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1996. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin. Infect. Dis. 23:550-555.
13. Huang, M. B., C. N. Baker., S. Banerjee, and F. C. Tenover. 1992. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30:3243-3248.
14. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Ratner, H. 1984. Flavobacterium meningosepticum. Infect Control 5:237-239.
16. Sanchez, M. L., M. S. Barrett, and R. N. Jones. 1992. The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent β-lactamases. Diagn. Microbiol. Infect. Dis. 15:459-463.
17. Scully, B. E., and H. C. Neu. 1986. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J. Antimicrob. Chemother. 18(Suppl. D):179-185.
18. Sheridan, R. I., C. M. Ryan, M. S. Pasternack, J. M. Weber, and R. G. Tompkins. 1993. Flavobacterial sepsis in massively burned pediatric patients. Clin. Infect. Dis. 17:185-187.
19. Siegman-Igra, Y., D. Schwartz, G. Soferman, and N. Konforti. 1987. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med. Microbiol. Immunol. 176:103-111.
20. Strandberg, D. A., J. H. Jorgensen, and D. J. Drutz. 1983. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob. Agents Chemother. 24:282-286.
21. Tam, A. Y. C., R. W. H. Yung, and K. Fu. 1989. Fatal pneumonia caused by Flavobacterium meningosepticum. Pediatr. Infect. Dis. J. 8:252-254.
22. von Graevenitz, A., and M. Grehn. 1977. Susceptibility studies of Flavobacterium IIb. FEMS Microbiol. Lett. 2:289-292.